We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+57.48%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$514M
AUM Growth
-$7.79M
Cap. Flow
-$48M
Cap. Flow %
-9.34%
Top 10 Hldgs %
56.23%
Holding
206
New
96
Increased
32
Reduced
19
Closed
50

Top Buys

Rank Stock Value
1
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$11.2M
2
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$11.1M
3
ASXC
Asensus Surgical, Inc.
ASXC
+$8.33M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$8.2M
5
WIMI
WiMi Hologram Cloud
WIMI
+$8.14M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$31.5M
2
AZN icon
AstraZeneca
AZN
+$18.2M
3
MRNA icon
Moderna
MRNA
+$12.1M
4
XWEL icon
XWELL
XWEL
+$6.41M
5
CVM icon
CEL-SCI Corp
CVM
+$3.62M

Sector Composition

Rank Sector Weight
1 Healthcare 13.44%
2 Technology 2.48%
3 Consumer Staples 2.16%
4 Communication Services 1.48%
5 Financials 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTC icon
26
MMTec
MTC
$328M
$3.46M 0.67%
+16,886
New +$3.44M
VTSI icon
27
VirTra
VTSI
$33.9M
$3.45M 0.67%
+561,088
New +$2.67M
AMRN
28
CALL
Amarin Corp
AMRN
$293M
$3.44M 0.67%
277
+17
+7% +$2.29K
IMG
29
DELISTED
CIMG Inc
IMG
$3.37M 0.66%
+1,379
New +$7.02M
HMCO
30
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$3.35M 0.65%
+336,211
New +$3.5M
LFWD icon
31
ReWalk Robotics
LFWD
$19.6M
$3.13M 0.61%
15,380
+13,090
+572% +$3.01M
NMTR
32
PUT
DELISTED
9 Meters Biopharma
NMTR
$3.06M 0.6%
1,310
+569
+77% +$17.5K
AUTL
33
Autolus Therapeutics
AUTL
$386M
$3.01M 0.59%
+525,230
New +$3.89M
BIIB icon
34
PUT
Biogen
BIIB
$30.4B
$2.8M 0.54%
100
-1,924
-95% -$519K
ASLN
35
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$2.74M 0.53%
+20,429
New +$2.59M
CVM.WS
36
CALL
DELISTED
Cel-Sci Corp Series S
CVM.WS
$2.68M 0.52%
1,760
+489
+38% +$744K
ATOS icon
37
PUT
Atossa Therapeutics
ATOS
$24.1M
$2.67M 0.52%
+845
New +$30.9K
CHRN
38
ChronoScale Holdings
CHRN
$2.94B
$2.61M 0.51%
+28,224
New +$3.39M
STAB
39
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$2.51M 0.49%
+478,941
New +$2.62M
MRTX
40
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.48M 0.48%
145
– –
IONS icon
41
Ionis Pharmaceuticals
IONS
$9.14B
$2.46M 0.48%
+54,688
New +$3.05M
RVPH
42
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$2.4M 0.47%
20,922
+3,007
+17% +$502K
XWEL icon
43
PUT
XWELL
XWEL
$8.87M
$2.39M 0.46%
648
+435
+204% +$16.6K
LSTA icon
44
PUT
Lisata Therapeutics
LSTA
$10.6M
$2.31M 0.45%
797
+790
+11,286% +$23.9K
ASXC
45
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
$2.26M 0.44%
6,959
+6,104
+714% +$22.1K
ORIO
46
Orion Digital Corp
ORIO
$15.6M
$2.26M 0.44%
+88,609
New +$1.93M
CVM.WS
47
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
$2.2M 0.43%
1,448
-4,055
-74% -$6.17M
ODT
48
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$2.17M 0.42%
634,728
+586,783
+1,224% +$11.1M
TRIL
49
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.14M 0.42%
199,569
+79,573
+66% +$984K
ASXC
50
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$2.13M 0.41%
+6,556
New +$23.7K
1
2
3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2021 Portfolio in Review

As of Q1 2021, Sabby Management held 206 positions worth $514M, down 1.5% from $522M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sabby Management withdrew a net $48M in Q1 2021, closing 50 positions and reducing 19 holdings. Its most notable exit was Biogen, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Sabby Management opened a new position in Sorrento Therapeutics, Inc. worth $8.81M.

  • Sabby Management's largest Q1 2021 buy was Sorrento Therapeutics, Inc.: 1,064,933 shares worth $8.81M.
  • Sabby Management added most to Odonate Therapeutics, Inc. Common Stock in Q1 2021, an estimated $11.1M increase.
  • Sabby Management's biggest Q1 2021 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $494K.
  • Sabby Management fully exited Biogen in Q1 2021, selling an estimated $31.5M.
  • Sabby Management's ten largest holdings make up 56% of its $514M portfolio in Q1 2021.
  • Sabby Management opened 96 new positions and closed 50 in Q1 2021.
  • Sabby Management's portfolio value fell 1.5% quarter-over-quarter to $514M.

Based on Sabby Management's 13F filing for Q1 2021, filed 17 May 2021.